Each ml of this medicine contains insulin lispro 100 units, 16 mg glycerin, 1.88 mg dibasic sodium phosphate, 3.15 mg Metacresol, phenol, and water for injection.


It is indicated in adult and pediatric patients to improve glycemic control.

Side effects

Mild to moderate side effect has been observed such as hypoglycemia, lipodystrophy, rash, pruritus, weight gain


This drug is to be cautiously used in patients with renal disease, thyroid, hypokalemia, hepatic impairment, pregnancy, and breastfeeding


It is contraindicated in patients with episodes of hypoglycemia, hypersensitivity

Dosage and administration

It is available as 100 units/ml(U-100) and 200 units/ml(U-200) doses are administrated subcutaneously within fifteen minutes before or after a meal.


(We have also established roots and begun this new venture in other countries as well such as Argentina, France , Oman, Cayman, Samoa)

Available Forms